Research Catalog

Accelerating the development of biomarkers for drug safety : workshop summary

Title
Accelerating the development of biomarkers for drug safety : workshop summary / Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
Author
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Publication
Washington, D.C. : National Academies Press, [2009], ©2009.

Items in the Library & Off-site

Filter by

2 Items

StatusFormatAccessCall NumberItem Location
Request for On-site UseRequest Scan
How do I pick up this item and when will it be ready?
TextRequest in advance R853.B54 I58 2009gOff-site
Not available - Please for assistance.
TextUse in library Off-site

Holdings

Details

Additional Authors
  • Olson, Steve, 1956-
  • Robinson, Sally.
  • Giffin, Robert B.
  • National Research Council (U.S.). Planning Committee for Assessing and Accelerating the Development of Biomarkers for Drug Safety : a Workshop.
  • Assessing and Accelerating the Development of Biomarkers for Drug Safety. Workshop (2008 : Washington, D.C.)
Description
xv, 83 pages : illustrations; 23 cm
Summary
"Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a more focused and rational pathway to drug development. On October 24, 2008, the IOM's Forum on Drug Discovery, Development, and Translation held 'Assessing and Accelerating Development of Biomarkers for Drug Safety,' a one-day workshop, summarized in this volume, on the value of biomarkers in helping to determine drug safety during development."--Publisher's website.
Subjects
Bibliography (note)
  • Includes bibliographical references (p. 55-57).
Additional Formats (note)
  • Also available online.
Contents
Introduction -- Overview Of key issues -- Cardiac safety biomarkers -- Assessing and predicting kidney safety -- Biomarkers of acute idiosyncratic hepatocellular injury in clinical trials -- Future considerations.
ISBN
  • 9780309131247 (pbk.)
  • 0309131243 (pbk.)
OCLC
  • ocn431872188
  • 431872188
  • SCSB-5484396
Owning Institutions
Columbia University Libraries